RxDoctor Payments Data

Jason Gass, DO

Internal Medicine · Saint Louis, MONPI 1700224201

Payments from drug & device makers

$2,305in general payments, 2019–2025

Across 141 payments — averaging $16.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$496
  • Gilead$461
  • Viiv Healthcare Company$323
  • Merck$197
  • Insmed, Inc.$177
  • Shionogi Inc$149
  • plus $502 from 13 others

What the payments were for

  • Food & beverage$2,26798%
  • Education$382%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,305 in reported general payments places this provider in the 80th percentile of 2,097 internal medicine providers in Missouri.

See all internal medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$69,210
Medicare patients
189
Services billed
775

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala30$160,451
Daptomycin25$30,285
ErtapenemErtapenem Sodium29$14,342
Vancomycin Hcl56$5,767
Cefepime Hcl14$4,474
CeftriaxoneCeftriaxone Sodium78$4,319
Methenamine Hippurate45$4,018
Piperacillin-TazobactamPiperacillin Sodium/Tazobactam18$3,962
Doxycycline Hyclate77$2,080
Rifampin34$1,619
Ceftazidime38$1,225
Cefadroxil53$923
Ethambutol Hcl20$897
Azithromycin52$719
Tobramycin Sulfate48$595

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy$461$160,45130 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,097 internal medicine providers in Missouri.

Other internal medicine in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →